December 29, 2010 โ Patient enrollment has been completed for a Phase III trial of an oral Factor Xa inhibitor. The ENGAGE AF-TIMI 48 study will investigate edoxaban, by Daiichi Sankyo, for preventing strokes and systemic embolic events (SEE) in patients with atrial fibrillation (AF).
December 29, 2010 โ The U.S. Food and Drug Administration (FDA) has approved a stent graft system for treating abdominal aortic aneurysms (AAA). The Endurant AAA Stent Graft System, from Medtronic, can be used for the minimally invasive treatment of the often fatal condition.
December 29, 2010 โ An international trial for a self-apposing stent has begun, with 50 of the total 500 patients already enrolled. The APPOSITION III trial will look at the Stentys self-apposing stent in treating acute myocardial infarction (AMI).
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
December 29, 2010 - America is winning a battle against heart disease and stroke mortality, but is still losing the war, according to the American Heart Association.
December 27, 2010 โ A case report in Circulation describes the association of stent thrombosis with lipid core plaque as detected by the LipiScan Coronary Imaging System. The LipiScan is the first and only FDA-approved system to provide a chemogram (map of lipid core plaque) within the imaged vessel via near-infrared (NIR) spectroscopy.
December 27, 2010 โ The U.S. Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure. It combines the only approved direct renin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
December 22, 2010 โ Dell today announced its intent to acquire cloud-based medical archiving company InSite One Inc. to help healthcare organizations simplify retention of healthcare data.
December 22, 2010 โ Thanks to advances in space technology, an iPhone will soon be able to do double-duty, keeping people in tune with their favorite music and their vital signs while they go for a jog.
December 22, 2010 โ The first implants of the Medtronic CoreValve transcatheter aortic valve were made this week in the pivotal U.S. clinical trial.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 21, 2010 โ A new service has been launched that provides 24-hour, Web-based remote monitoring follow-up services for patients with pacemakers. The service, from Philips, is the first large-scale service of its kind in the United States. It was made available to cardiology services as a beta version in August.
December 21, 2010 - The outcome of a recent expert consensus workshop offers six specific research recommendations in high-priority areas for sudden cardiac death (SCD) prediction and prevention. In the United States, SCD claims more than 250,000 lives annually and is the cause of half of all heart disease deaths.
December 21, 2010 โ A new introducer kit is now available in the United States. The VSI StraitSet Kit, from Vascular Solutions, contains a triaxial introducer comprising a 6 French, a 20 cm sheath, inner dilator and metal stiffening cannula.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
December 21, 2010 โ A once-daily, three-in-one combination blood pressure treatment has been approved in Germany. Sevikar HCT, from Daiichi Sankyo Europe, combines olmesartan medoxomil, amlodipine, and hydrochlorothiazide (HCT) in one pill to help control hypertension.
December 20, 2010 โ A magnetic resonance (MR) system with high slew rate gradients and a new user interface is pending 510(k) approval and was announced at the Radiological Society of North America (RSNA) annual meeting. The Vantage Titan HSR 1.5T MR, by Toshiba, is ideal for exams, such as advanced cardiac and neuro imaging, that require higher image quality and faster exams.
December 17, 2010 โ Data published in Circulation: Cardiovascular Interventions showed that a protein used with coronary stents significantly reduced two key biomarkers of cardiac damage in patients with acute coronary syndrome (ACS). VT-111, a protein produced by the myxoma virus, was used by Viron Therapeutics.